This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wasilenko, W J
Right arrow Articles by Weber, M J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wasilenko, W J
Right arrow Articles by Weber, M J

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 March; 10(3): 1254-1258

Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src.

W J Wasilenko, M Nori, N Testerman and M J Weber

Department of Microbiology and Cancer Center, University of Virginia Health Sciences Center, Charlottesville 22908.

ABSTRACT

We have previously shown that an intracellular mechanism down regulates epidermal growth factor (EGF) receptor levels in rodent fibroblasts transformed by the src oncogene (W. J. Wasilenko, L. K. Shawver, and M. J. Weber, J. Cell. Physiol. 131:450-457, 1987). We now report that this down regulation is due to an inhibition of EGF receptor biosynthesis. With Rat-1 (R1) cells infected with a temperature-sensitive src mutant, we found that 125I-labeled EGF binding to cells began to decrease soon after the activation of pp60v-src by shift down to the permissive temperature for transformation. This effect of src on EGF receptors was reversible. Pulse-chase studies with [35S]methionine-labeled cells revealed that the tyrosine protein kinase activity of pp60v-src had little if any effect on EGF receptor degradation rate. By contrast, the expression of pp60v-src caused a large reduction in the apparent rate of EGF receptor biosynthesis. Northern (RNA) blot analysis demonstrated that pp60v-src also caused marked reductions in the steady-state level of EGF receptor mRNA. These data indicate that one way the expression of the src oncogene can affect the machinery of growth control is by affecting the expression of specific genes for growth factor receptors.


Mol Cell Biol. 1990 March; 10(3): 1254-1258




This article has been cited by other articles:

  • Platek, A., Mettlen, M., Camby, I., Kiss, R., Amyere, M., Courtoy, P. J. (2004). v-Src accelerates spontaneous motility via phosphoinositide 3-kinase, phospholipase C and phospholipase D, but abrogates chemotaxis in Rat-1 and MDCK cells. J. Cell Sci. 117: 4849-4861 [Abstract] [Full Text]  
  • Kuo, M.-L., Chau, Y.-P., Wang, J.-H., Lin, P.-J. (1997). The Role of Src Kinase in the Potentiation by Ethanol of Cytokine- and Endotoxin-Mediated Nitric Oxide Synthase Expression in Rat Hepatocytes. Mol. Pharmacol. 52: 535-541 [Abstract] [Full Text]  
  • Rebut-Bonneton, C, Boutemy-Roulier, S, Evain-Brion, D (1993). Modulation of pp60c-src activity and cellular localization during differentiation of human trophoblast cells in culture. J. Cell Sci. 105: 629-636 [Abstract]